JPH0643390B2 - アザシクロアルカン誘導体 - Google Patents

アザシクロアルカン誘導体

Info

Publication number
JPH0643390B2
JPH0643390B2 JP61079174A JP7917486A JPH0643390B2 JP H0643390 B2 JPH0643390 B2 JP H0643390B2 JP 61079174 A JP61079174 A JP 61079174A JP 7917486 A JP7917486 A JP 7917486A JP H0643390 B2 JPH0643390 B2 JP H0643390B2
Authority
JP
Japan
Prior art keywords
compound
drug
present
hours
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP61079174A
Other languages
English (en)
Japanese (ja)
Other versions
JPS62238261A (ja
Inventor
正義 辻
寿孝 井上
照美 八谷
幹夫 中島
勝 斉田
雄治 下園
真澄 香月
美智順 境
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hisamitsu Pharmaceutical Co Inc
Original Assignee
Hisamitsu Pharmaceutical Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hisamitsu Pharmaceutical Co Inc filed Critical Hisamitsu Pharmaceutical Co Inc
Priority to JP61079174A priority Critical patent/JPH0643390B2/ja
Priority to EP87200183A priority patent/EP0241050B1/en
Priority to ES198787200183T priority patent/ES2046196T3/es
Priority to DE8787200183T priority patent/DE3782182T2/de
Priority to AT87200183T priority patent/ATE81505T1/de
Priority to KR1019900702502A priority patent/KR910000480B1/ko
Priority to KR1019870701153A priority patent/KR910000164B1/ko
Priority to CA000529377A priority patent/CA1336597C/en
Priority to AU70207/87A priority patent/AU601402B2/en
Priority to KR1019900702501A priority patent/KR910000479B1/ko
Priority to PCT/JP1987/000086 priority patent/WO1987006226A2/en
Priority to AR87306713A priority patent/AR245107A1/es
Priority to CN91109720A priority patent/CN1020605C/zh
Priority to CN87100666A priority patent/CN1018452B/zh
Publication of JPS62238261A publication Critical patent/JPS62238261A/ja
Priority to US07/131,193 priority patent/US4882359A/en
Priority to SU874203780A priority patent/SU1748644A3/ru
Priority to SU894613462A priority patent/SU1750422A3/ru
Priority to SU894613514A priority patent/SU1750423A3/ru
Priority to KR9072500A priority patent/KR910000478B1/ko
Priority to CN 91109721 priority patent/CN1019573B/zh
Priority to GR930400029T priority patent/GR3006768T3/el
Publication of JPH0643390B2 publication Critical patent/JPH0643390B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • C07D207/263—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms
    • C07D207/267—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to the ring nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • C07D207/263—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms
    • C07D207/27—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D211/74—Oxygen atoms
    • C07D211/76—Oxygen atoms attached in position 2 or 6
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/02—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D223/06—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D223/08—Oxygen atoms
    • C07D223/10—Oxygen atoms attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • C07D265/32—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings with oxygen atoms directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/08—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D277/12—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/14—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/10—1,4-Thiazines; Hydrogenated 1,4-thiazines
    • C07D279/12—1,4-Thiazines; Hydrogenated 1,4-thiazines not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D281/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D281/02—Seven-membered rings
    • C07D281/04—Seven-membered rings having the hetero atoms in positions 1 and 4
    • C07D281/06—Seven-membered rings having the hetero atoms in positions 1 and 4 not condensed with other rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyrrole Compounds (AREA)
JP61079174A 1986-04-08 1986-04-08 アザシクロアルカン誘導体 Expired - Lifetime JPH0643390B2 (ja)

Priority Applications (21)

Application Number Priority Date Filing Date Title
JP61079174A JPH0643390B2 (ja) 1986-04-08 1986-04-08 アザシクロアルカン誘導体
EP87200183A EP0241050B1 (en) 1986-04-08 1987-02-07 Azacycloalkane derivatives, absorption promoters containing the derivatives as the effective ingredient and external preparation containing the absorption promoters
ES198787200183T ES2046196T3 (es) 1986-04-08 1987-02-07 Derivados de azacicloalcanos, promotores de absorcion que contienen los derivados como ingrediente eficaz y preparaciones externas que contienen los promotores de absorcion.
DE8787200183T DE3782182T2 (de) 1986-04-08 1987-02-07 Azacycloalkanderivate, absorptionspromotoren, die die derivate als effektiven inhaltsstoff enthalten und aeusserlich anzuwendende praeparate, die absorptionspromotoren enthalten.
AT87200183T ATE81505T1 (de) 1986-04-08 1987-02-07 Azacycloalkanderivate, absorptionspromotoren, die die derivate als effektiven inhaltsstoff enthalten und aeusserlich anzuwendende praeparate, die absorptionspromotoren enthalten.
KR1019900702502A KR910000480B1 (ko) 1986-04-08 1987-02-10 아자시클로 알칸유도체의 제조방법
KR1019870701153A KR910000164B1 (ko) 1986-04-08 1987-02-10 아자시클로알칸유도체의 제조방법
CA000529377A CA1336597C (en) 1986-04-08 1987-02-10 Azacycloalkane derivatives, absorption promoters containing the derivatives as the effective ingredient and external preparations containing the absorption promoters
AU70207/87A AU601402B2 (en) 1986-04-08 1987-02-10 Azacycloalkane derivatives, absorption promoters containing the derivatives as the effective ingredient and external preparations containing the absorption promoters
KR1019900702501A KR910000479B1 (ko) 1986-04-08 1987-02-10 아자시클로알칸유도체의 제조방법
PCT/JP1987/000086 WO1987006226A2 (en) 1986-04-08 1987-02-10 Azacycloalkane derivatives, absorption promoters containing the derivatives as the effective ingredient and external preparations containing the absorption promoters
AR87306713A AR245107A1 (es) 1986-04-08 1987-02-11 Procedimiento para preparar derivados de azacicloalcano,promotores de absorcion que contienen a los derivados como el ingrediente eficaz y preparaciones externas que contienen a los promotores
CN87100666A CN1018452B (zh) 1986-04-08 1987-02-12 制备氮杂环烷烃衍生物的方法
CN91109720A CN1020605C (zh) 1986-04-08 1987-02-12 制备氮杂环烷烃衍生物的方法
US07/131,193 US4882359A (en) 1986-04-08 1987-11-18 Azacycloalkane derivatives, absorption promoters containing the derivatives as the effective ingredient and external preparations containing the absorption promoters
SU874203780A SU1748644A3 (ru) 1986-04-08 1987-12-07 Способ получени производных азациклоалкана
SU894613462A SU1750422A3 (ru) 1986-04-08 1989-02-13 Способ получени лактамов
SU894613514A SU1750423A3 (ru) 1986-04-08 1989-02-27 Способ получени лактамов
KR9072500A KR910000478B1 (en) 1986-04-08 1990-11-22 Process for preparing azacycloalkane derivatives
CN 91109721 CN1019573B (zh) 1986-04-08 1991-10-16 制备氮杂环烷烃衍生物的方法
GR930400029T GR3006768T3 (en]) 1986-04-08 1993-01-13

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP61079174A JPH0643390B2 (ja) 1986-04-08 1986-04-08 アザシクロアルカン誘導体

Publications (2)

Publication Number Publication Date
JPS62238261A JPS62238261A (ja) 1987-10-19
JPH0643390B2 true JPH0643390B2 (ja) 1994-06-08

Family

ID=13682615

Family Applications (1)

Application Number Title Priority Date Filing Date
JP61079174A Expired - Lifetime JPH0643390B2 (ja) 1986-04-08 1986-04-08 アザシクロアルカン誘導体

Country Status (14)

Country Link
US (1) US4882359A (en])
EP (1) EP0241050B1 (en])
JP (1) JPH0643390B2 (en])
KR (1) KR910000164B1 (en])
CN (2) CN1020605C (en])
AR (1) AR245107A1 (en])
AT (1) ATE81505T1 (en])
AU (1) AU601402B2 (en])
CA (1) CA1336597C (en])
DE (1) DE3782182T2 (en])
ES (1) ES2046196T3 (en])
GR (1) GR3006768T3 (en])
SU (3) SU1748644A3 (en])
WO (1) WO1987006226A2 (en])

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3779833T2 (de) * 1986-01-31 1993-02-04 Whitby Research Inc Zusammensetzungen enthaltend 1-substituierte azacycloalkane und deren verwendung.
US5472946A (en) * 1988-04-08 1995-12-05 Peck; James V. Transdermal penetration enhancers
CA1334646C (en) * 1988-04-08 1995-03-07 James Vanolden Peck Transdermal penetration enhancers
US5234959A (en) * 1988-04-08 1993-08-10 Whitby Research, Inc. Penetration enhancers for transdermal delivery of systemic agents
US5041435A (en) * 1988-08-13 1991-08-20 Santen Pharmaceutical Co., Ltd. Cyclic sulfur-containing compounds
ES2063369T3 (es) * 1989-08-03 1995-01-01 Hisamitsu Pharmaceutical Co Crema para la piel, para uso externo.
IL91928A (en) * 1989-10-08 1994-07-31 Amrad Res & Dev Pharmaceutical compositions containing prolactin
US5070084A (en) * 1990-02-26 1991-12-03 Campbell James N Treatment of sympathetically maintained pain
US6559186B1 (en) 1990-02-26 2003-05-06 Arc 1, Inc. Compositions and methods of treatment of sympathetically maintained pain
FR2663932B1 (fr) * 1990-06-29 1994-04-29 Cird Galderma N-alkyl oxo-1 et dioxo-1,1 thiamorpholinones-3 et leurs utilisations comme agents de penetration de composes actifs dans des compositions therapeutiques et cosmetiques.
JPH078806B2 (ja) * 1990-08-16 1995-02-01 旭化成工業株式会社 カルシトニン類含有経鼻投与用乳剤
FR2666962B1 (fr) * 1990-09-26 1996-06-14 Oreal Composition antifongique sous forme de spray sec.
US5158763A (en) * 1990-10-09 1992-10-27 Colgate-Palmolive Company Non-staining anti-bacterial oral composition
JPH07595B2 (ja) * 1990-10-31 1995-01-11 久光製薬株式会社 アザシクロアルカン誘導体の製造方法
US5206386A (en) * 1991-03-20 1993-04-27 Isp Investments Inc. Controlled release N-substituted pyrrolidone esters and process for the use thereof
JP3090353B2 (ja) * 1991-09-17 2000-09-18 旭化成工業株式会社 パラチロイドホルモン類含有経鼻投与用乳剤
EP0608433B1 (en) * 1992-07-13 2004-05-19 Shiseido Company, Ltd. Composition for dermatologic preparation
WO1995011042A1 (fr) * 1993-10-21 1995-04-27 Hisamitsu Pharmaceutical Co., Inc. Composition administree par voie nasale et preparation contenant celle-ci
DE4337945A1 (de) * 1993-11-06 1995-05-11 Labtec Gmbh Pflaster zur Behandlung von Nagelmykosen
GB9325854D0 (en) * 1993-12-17 1994-02-23 Smithkline Beecham Corp Porcess
US6262117B1 (en) 1999-02-18 2001-07-17 Allergan Sales, Inc. Method and composition for treating acne
JP2000247911A (ja) 1999-02-26 2000-09-12 Hisamitsu Pharmaceut Co Inc 大腸用吸収促進剤
JP4653282B2 (ja) * 2000-05-23 2011-03-16 昭和薬品化工株式会社 ミノサイクリン含有組成物
RU2311409C2 (ru) * 2003-01-10 2007-11-27 Ф.Хоффманн-Ля Рош Аг Производные 2-пиперидона в качестве агонистов простагландина
JP4504210B2 (ja) * 2005-01-25 2010-07-14 花王株式会社 染毛剤組成物
US8026266B2 (en) 2005-11-08 2011-09-27 Arcion Therapeutics, Inc. Treatment of length dependent neuropathy
CN118141709B (zh) * 2024-02-22 2025-04-22 北京逆之龄生物科技有限公司 一种抗衰老化妆品及其制备方法和应用

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4450102A (en) 1982-11-02 1984-05-22 Phillips Petroleum Company Sulfur based metal cleaners and corrosion inhibitors

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE871154C (de) * 1942-08-26 1953-03-19 Basf Ag Verfahren zur Herstellung oberflaechenwirksamer Verbindungen
GB947910A (en) * 1960-11-04 1964-01-29 Gen Aniline & Film Corp Surface active ethers of n-(hydroxymethyl)-lactams
US3188317A (en) * 1961-12-22 1965-06-08 Dow Chemical Co Oxazolidinone derivatives
US3228955A (en) * 1962-01-18 1966-01-11 Dow Chemical Co Certain substituted oxazolidinones and pyrrolidinones
DE1177641B (de) * 1962-06-12 1964-09-10 Kalk Chemische Fabrik Gmbh Verfahren zur Herstellung von N-(ª‰-Hydroxy-alkyl)-oxazolidonen-(4) bzw. deren Polyaether
DE1241830B (de) * 1962-11-02 1967-06-08 Kalk Chemische Fabrik Gmbh Verfahren zur Herstellung von AEthern des N-Methylol-2, 2, 5, 5-tetramethyloxazolidons-(4)
US3232952A (en) * 1963-09-20 1966-02-01 Kalk Chemische Fabrik Gmbh Di-(oxazolidinone-(4)-n-alkyl)-ethers
DE1695846A1 (de) * 1967-05-05 1971-05-13 Schwarzkopf Gmbh Hans Verfahren zur Darstellung von Thioaethern mit reduktiven Eigenschaften
DE2114295A1 (de) * 1970-03-27 1971-10-14 Gaf Corp Substituierte AEtherderivate des N-Hydroxymethyl-2-pyrrolidinon und Verfahren zu deren Herstellung
DE2114251A1 (de) * 1970-03-30 1971-10-14 Gaf Corp Tertiaere Aminomethylderivate des N-Hydroxymethyl-2-pyrrolidinon und Verfahren zu deren Herstellung
US3956313A (en) * 1970-04-13 1976-05-11 Gaf Corporation N-(substituted-thiomethyl)-2-pyrrolidinones
US3991203A (en) * 1975-06-19 1976-11-09 Nelson Research & Development Company Vehicle composition containing 1-substituted azacyclopentan-2-ones
US4415563A (en) * 1980-04-04 1983-11-15 Nelson Research & Development Company Vehicle composition containing 1-substituted azacyclononan-2-ones
US4424210A (en) * 1980-04-04 1984-01-03 Nelson Research & Development Company Vehicle composition containing 1-substituted azacycloalkan-2-ones
US4444762A (en) * 1980-04-04 1984-04-24 Nelson Research & Development Company Vehicle composition containing 1-substituted azacyclopentan-2-ones
US4423040A (en) * 1980-04-04 1983-12-27 Nelson Research & Development Company Vehicle composition containing 1-substituted azacyclohexan-2-ones
FR2525106B1 (fr) * 1982-04-15 1985-06-07 Oreal Composition cosmetique contenant en tant qu'agent actif sur l'elasticite et la souplesse de la peau, de la thiamorpholinone ou l'un de ses derives
FR2525220A1 (fr) * 1982-04-15 1983-10-21 Oreal Nouveaux derives substitues de la thiamorpholinone et leurs procedes de preparation

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4450102A (en) 1982-11-02 1984-05-22 Phillips Petroleum Company Sulfur based metal cleaners and corrosion inhibitors

Also Published As

Publication number Publication date
EP0241050B1 (en) 1992-10-14
JPS62238261A (ja) 1987-10-19
AR245107A1 (es) 1993-12-30
US4882359A (en) 1989-11-21
CN1018452B (zh) 1992-09-30
DE3782182D1 (de) 1992-11-19
EP0241050A3 (en) 1988-12-28
KR880701227A (ko) 1988-07-26
SU1748644A3 (ru) 1992-07-15
WO1987006226A3 (en) 1988-04-07
AU601402B2 (en) 1990-09-13
SU1750422A3 (ru) 1992-07-23
AU7020787A (en) 1987-11-09
ES2046196T3 (es) 1994-02-01
GR3006768T3 (en]) 1993-06-30
DE3782182T2 (de) 1993-02-25
EP0241050A2 (en) 1987-10-14
CN1060287A (zh) 1992-04-15
CN1020605C (zh) 1993-05-12
CA1336597C (en) 1995-08-08
KR910000164B1 (ko) 1991-01-21
ATE81505T1 (de) 1992-10-15
CN87100666A (zh) 1987-10-21
WO1987006226A2 (en) 1987-10-22
SU1750423A3 (ru) 1992-07-23

Similar Documents

Publication Publication Date Title
JPH0643390B2 (ja) アザシクロアルカン誘導体
EP0173990B1 (en) External pharmaceutical composition
US4746675A (en) External pharmaceutical composition
AU757086B2 (en) Topical compositions for prostaglandin E1 delivery
US5082866A (en) Biodegradable absorption enhancers
KR101662186B1 (ko) 경피 전달 시스템
KR20010042626A (ko) 활성 성분의 흡수 강화를 위한 활성을 갖는 화합물을함유하는 약학적 조성물
JPS60224638A (ja) 経皮吸収促進剤およびこれを含有する外用剤
JPS611623A (ja) 局所薬および全身薬の皮膚および膜を介する透過促進組成物およびその方法
AU2010336018B2 (en) Carrier composition
HUP0302452A2 (hu) Prosztaglandin E1-et tartalmazó topikus gyógyászati készítmények
JP3207212B2 (ja) 吸収促進剤およびこれを含有する外用剤
RU2165265C2 (ru) Усилители абсорбции для фармацевтических композиций местного применения
JP2538513B2 (ja) 吸収促進剤および該吸収促進剤を含有する外用製剤
JP2001288086A (ja) 皮膚疾患の治療用又は予防用外用剤
JP2001072605A (ja) 経皮経粘膜吸収促進剤組成物
KR910000480B1 (ko) 아자시클로 알칸유도체의 제조방법
JP3538370B2 (ja) 皮膚の色素異常症、瘢痕等の治療用又は予防用外用剤
CA2442479C (en) Topical compositions for prostaglandin e1 delivery
KR910000479B1 (ko) 아자시클로알칸유도체의 제조방법
JPH0478620B2 (en])
JPS62129274A (ja) アザシクロアルカン誘導体
JPH0730029B2 (ja) １−置換アザシクロヘプタン−２−オン及びこれを含有する経皮投与用薬剤
JPH0788360B2 (ja) １−置換アザシクロヘキサン−２−オン及びこれを含有する経皮投与用薬剤
JPS62164662A (ja) アザシクロアルカン誘導体および該誘導体を吸収促進活性成分とする吸収促進剤

Legal Events

Date Code Title Description
EXPY Cancellation because of completion of term